Phosphatase Cleavable Linker

Phosphatase-cleavable linkers are enzyme-responsive linker systems designed to exploit phosphatase-mediated hydrolysis for controlled intracellular payload release, particularly within lysosomal compartments enriched with phosphatases and pyrophosphatases^[1][1]. These linkers commonly incorporate phosphate or pyrophosphate motifs that undergo enzymatic cleavage after cellular internalization, enabling sequential activation through phosphatase-sensitive and self-immolative mechanisms^[1][2]. Mechanistically, phosphate-based linker architectures are engineered to maintain plasma stability while promoting cleavage in intracellular compartments, thereby improving the balance between systemic stability and site-specific drug release^[1][3]. In antibody-drug conjugate (ADC) research, phosphatase-cleavable designs have attracted interest because phosphate-containing structures increase aqueous solubility and may reduce aggregation of highly hydrophobic payload conjugates^[1][1]. Disease-focused applications have primarily been explored in oncology models, where phosphatase-responsive linkers are integrated into targeted delivery systems for selective release of cytotoxic agents or glucocorticoid payloads following tumor-cell internalization^[1][2]. Compared with more established protease-cleavable peptide linkers such as valine-citrulline systems, phosphatase-cleavable linkers rely on phosphatase activity rather than protease recognition, providing a distinct enzymatic release mechanism and an alternative strategy for linker optimization^[1][2]. For experimental applications, reported phosphate- and pyrophosphate-containing linkers have demonstrated high plasma stability, rapid lysosomal processing, and efficient payload release, supporting their continued evaluation in next-generation ADC development^[1][2].